Search Results - "Syversen SW"

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

Authors: Gehin JE Klaasen RA Kristianslund EK et al.

Source: Therapeutic drug monitoring [Ther Drug Monit] 2026 Aug 01; Vol. 48 (4), pp. 481-486. Date of Electronic Publication: 2026 Feb 02.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE

Editorial: does anti‐TNF 'treatment persistence' always equate to 'effective treatment'? Only objective disease assessments can answer the question. Authors' reply.

Authors: Blesl, Andreas Högenauer, Christoph Borenich, Andrea et al.

Source: Alimentary Pharmacology & Therapeutics. Sep2021, Vol. 54 Issue 5, p720-721. 2p. 1 Graph.

Exploration and discovery of treatment targets for primary biliary cholangitis based on plasma and cerebrospinal fluid proteomics: A multicenter mendelian randomization study.

Authors: Xi, Jianxin Wang, Shengnan Chen, Jie et al.

Source: PLoS ONE. 2/12/2026, Vol. 21 Issue 2, p1-15. 15p.

Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn's disease: a real-world retrospective cohort study.

Authors: Liu, Xiaoyu Yan, Yuehua Yi, Jiaqin et al.

Source: BMC Gastroenterology. 10/10/2025, Vol. 25 Issue 1, p1-13. 13p.

Author Index.

Source: Scandinavian Journal of Rheumatology. Aug2021, Vol. 50 Issue 130, p94-95. 2p.

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.

Authors: Kared H Jyssum I Alirezaylavasani A et al.

Source: Frontiers in immunology [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1296273. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.

Authors: Fu, Zhong‐Chao Cheng, Xiao‐Gui Zhang, Guo‐Wen et al.

Source: International Journal of Rheumatic Diseases. May2024, Vol. 27 Issue 5, p1-3. 3p.

Radiographic outcome over 15 years in patients with early rheumatoid arthritis - a BARFOT-study.

Authors: Andersson MLE Hafström I Forslind K

Source: BMC rheumatology [BMC Rheumatol] 2026 May 27; Vol. 10 (1). Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101738571 Publication Model: Electronic Cited Medium: Internet ISSN: 2520-1026 (Electronic) Linking ISSN: 25201026 NLM ISO Abbreviation: BMC Rheumatol Subsets: PubMed not MEDLINE

Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.

Authors: Kiltz, Uta Chen, Yi-Ming Rubbert-Roth, Andrea et al.

Source: Rheumatology & Therapy. Aug2026, Vol. 13 Issue 4, p899-930. 32p.

Abnormal Ulnar Variance: A New Perspective in Rheumatoid Arthritis-Related Joint Damage.

Authors: Ketenci, Sertaç Pekdiker, Mete Uzuner, Bora et al.

Source: Archives of Rheumatology. Jun2025, Vol. 40 Issue 2, p164-170. 7p.

Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus.

Authors: Yoshijima, Chisato Suzuki, Yosuke Tanaka, Ryota et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-7. 7p.

Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.

Authors: Gehin, JE Warren, DJ Syversen, SW et al.

Source: Scandinavian Journal of Rheumatology. Nov 2021, Vol. 50 Issue 6, p445-454. 10p.

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Authors: Gehin JE Klaasen RA Klami Kristianslund E et al.

Source: RMD open [RMD Open] 2024 Nov 13; Vol. 10 (4). Date of Electronic Publication: 2024 Nov 13.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE

The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.

Authors: Magro, Fernando Fernandes, Samuel Patita, Marta et al.

Source: Journal of Crohn's & Colitis. Jul2024, Vol. 18 Issue 7, p1102-1112. 11p.

Differences in referral path, clinical and radiographic outcomes between seronegative and seropositive rheumatoid arthritis Mexican Mestizo patients: A cohort study.

Authors: Guaracha-Basáñez, Guillermo Arturo Contreras-Yáñez, Irazú Ortiz-Haro, Ana Belén et al.

Source: PLoS ONE. 6/6/2024, Vol. 19 Issue 6, p1-19. 19p.

Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis.

Authors: Leclercq, Mathilde Goupillou, Paul Gomez, Hélène et al.

Source: Journal of Ophthalmic Inflammation & Infection. 7/18/2023, Vol. 13 Issue 1, p1-6. 6p.

Wnt signaling as a translational target in rheumatoid and psoriatic arthritis.

Authors: Riitano, Gloria Spinelli, Francesca Manganelli, Valeria et al.

Source: Journal of Translational Medicine. 2/4/2025, Vol. 23 Issue 1, p1-10. 10p.

Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?

Authors: Arrivé C Hotot M Jourdil JF et al.

Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 693-712. Date of Electronic Publication: 2026 Jun 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE

Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe.

Authors: Skrede, Silje Bogavac‐Stanojević, Nataša Dreesen, Erwin et al.

Source: Basic & Clinical Pharmacology & Toxicology. Apr2024, Vol. 134 Issue 4, p556-560. 5p.

Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST.

Authors: Peyrin‐Biroulet, Laurent Vermeire, Séverine D'Haens, Geert et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2024, Vol. 59 Issue 2, p175-185. 11p.